SCHEMBL25907886

SCHEMBL25907886

CC(=O)CCC(C(N)=O)N1Cc2c(O)cccc2C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ CRBN Q96SW2 1/20 0.36
▸ POLB P06746 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MAPT P10636 3/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ APEX1 P27695 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17343919 1.00 ALOX15 (0.37) ALOX15KDM4ECRBNPOLBALDH1A1
SCHEMBL15472383 0.90 ALOX15 (0.39) ALOX15KDM4ECRBNPOLBALDH1A1
SCHEMBL20425363 0.89 KDM4E (0.45) ALOX15KDM4ECRBNPOLBALDH1A1
SCHEMBL2257304 0.89 KDM4E (0.45) ALOX15KDM4ECRBNPOLBALDH1A1
SCHEMBL19222240 0.89 ALOX15 (0.39) ALOX15KDM4ECRBNPOLBALDH1A1
SCHEMBL6368923 0.88 KDM4E (0.37) ALOX15KDM4ECRBNPOLBALDH1A1
SCHEMBL19603302 0.88 ALOX15 (0.34) ALOX15KDM4ECRBNPOLBALDH1A1
SCHEMBL2248688 0.87 NPC1 (0.40) ALOX15KDM4ECRBNPOLBALDH1A1
SCHEMBL2251395 0.87 NPC1 (0.40) ALOX15KDM4ECRBNPOLBALDH1A1
SCHEMBL29471925 0.87 NPC1 (0.40) ALOX15KDM4ECRBNPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912644-B2 Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate CELGENE CORPORATION (US) 2024-02-27 — — US disclosed
US-20230234914-A1 PROCESSES FOR THE PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE CELGENE CORPORATION 2023-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234914-A1 PROCESSES FOR THE PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE UMPS, DHPS, NT5C3B ALOX15 1195/4885KDM4E 521/4885CRBN 4789/4885
US-11912644-B2 Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate UMPS, DHPS, NT5C3B ALOX15 1195/4885KDM4E 521/4885CRBN 4789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback